StrainX Bioworks, a synthetic biology and precision fermentation startup headquartered in Bengaluru, has secured $13 million in funding co-led by Prime Venture Partners and Leo Capital, according to an announcement.
The round also drew backing from several other investors, including Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, and WindT Angels.
Founded by IIT Delhi alumni Akshay Mittal and Alok Malaviya, the startup focuses on precision fermentation and strain engineering to develop bio-based ingredients and solutions for sectors ranging from food to healthcare. The company operated in stealth mode over the past two years while building its research and engineering capabilities.
Currently, it has a team of more than 100 scientists, engineers, and operators, including 15 PhDs.
StrainX plans to use the capital to strengthen its research and development efforts, expand its scientific and engineering teams, and advance commercialisation through large-scale fermentation projects and global partnerships.
The funding comes at a time when India is steadily evolving from a low-cost biotech manufacturing destination into a global centre for synthetic biology and precision fermentation-driven innovation.
As demand grows for sustainable and bio-based alternatives, startups in the space are increasingly attracting investor interest and international partnerships.
Among other startups in the sector to have raised funding, Genexis Biotech secured a seed round last year led by GVFL, with participation from Benzai10.
Both Prime Venture Partners and Leo Capital are early stage venture capital firms that back technology-driven startups. Leo Capital also invests in markets across Southeast Asia and Europe.
